Table 2 Comorbidities among CVDs patients in the PCS

Comorbidity

One

71 (7.4)

11 (15.4; 8.7–25.8)

 < 0.001

Two or three

319 (33.2)

83 (26.0; 21.4–31.1)

More than 3

571 (59.4)

280 (49.0; 44.9–53.1)

Hypertension

No

547 (56.9)

152 (27.7; 24.1–31.6)

 < 0.001

Yes

414 (43.1)

222 (53.6; 47.8–58.3)

Diabetes miletus

No

783 (81.5)

262 (33.4; 30.2–36.8)

 < 0.001

Yes

178 (18.5)

112 (62.9; 55.5–69.7)

Jaundice

No

926 (96.4)

358 (38.6; 35.5–41.8)

0.401

Yes

35 (3.6)

16 (45.7; 30.2–62.1)

Rheumatic heart disease

No

954 ( 99.3)

371 (38.8; 35.8–42.0)

0.830

Yes

7 (0.7)

3 (42.8; 14.3–77.0)

Joint pain

No

315 (32.8)

95 (30.1; 25.3–35.4)

 < 0.001

Yes

646 (67.2)

279 (43.1; 39.4–47.0)

Back pain

No

398 (41.4)

129 (32.4; 27.9–37.1)

0.001

Yes

563 (58.6)

254 (43.5; 39.4–47.6)

Anxiety

No

531 (55.3)

163 (30.6; 26.9–34.7)

 < 0.001

Yes

430 (44.7)

211 (49.0; 44.3–53.7)

Depression

No

654 (68.1)

214 (32.7; 29.2–36.4)

 < 0.001

Yes

307 (31.9)

160 (52.1; 46.5–57.6)

Insomnia

No

698 (72.6)

257 (36.8; 33.3–40.4)

0.030

Yes

263 (27.4)

117 (44.4; 38.5–50.5)

Obstructive lung disease

No

893 (92.9)

336 (37.6; 34.5–40.8)

0.003

Yes

68 (7.1)

38 (55.8; 43.9–67.1)

Stroke

No

910 (94.7)

350 (38.4; 35.3–41.6)

0.220

Yes

51 (5.3)

24 (47.0; 33.8–60.6)

Renal failure

No

941 (97.9)

364 (38.6; 35.6–41.8)

0.304

Yes

20 (2.1)

10 (50.0; 29.3–70.6)

GERD

No

630 (65.6)

232 (36.8; 33.1–40.6)

0.066

Yes

331 (34.4)

142 (42.9; 37.6–48.3)

IBS

No

803 (84.5)

300(37.3; 34.0–40.7)

0.028

Yes

147 (15.5)

147 (46.9; 39.0–55.0)

Functional constipation

No

841 (87.5)

316 (37.5; 34.3–40.9)

0.024

Yes

120 (12.5)

58 (48.3; 39.5–57.2)

Cancer

No

947 (98.5)

371 (39.1; 36.1–42.3)

0.176

Yes

14 (1.5)

3 (21.4; 7.0–49.4)